Quick answer: The ROI of prior authorization software for a PE-backed MSO comes from three sources — reduced loaded labor cost per PA (typically $11 manual to $5 automated, per CAQH), faster time-to-revenue from higher first-pass approval rates, and the ability to flex existing PA staff across more practice volume without rehiring as the MSO scales. For a typical PE-backed MSO with 5–10 acquired practices, year-two annual benefit lands in the $400,000–$1.2M range against $100,000–$200,000 in platform cost, with payback inside 6–9 months and a second-order ROI on portfolio scalability that's often larger than the direct labor recovery.
Why PE-backed MSO ROI math looks different from independent practice ROI math
A 15-provider independent practice evaluating PA software runs a clean ROI model — labor recovery on the current PA workflow, first-pass approval rate lift, revenue recovery from PAs that previously dropped. The math typically lands at 3–5x annually and pays back in 6–10 months. A PE-backed MSO running the same evaluation across 10 acquired practices has additional ROI lines that don't show up at single-practice scale.
The biggest difference is the portfolio scalability line. PE-backed MSOs are buying acquired practices on the thesis that operational consolidation will recover purchase-price multiples. Centralized PA is one of the highest-leverage operational moves in that thesis because the per-PA labor cost compounds across every acquired practice and across every future acquisition. A platform that lets the MSO add the next acquired practice's PA volume without proportionally growing the PA headcount changes the entire shape of the MSO's economic model — not just this year's P&L.
The 2024 CAQH Index pegs manual PA at $10.97 per request versus $5.79 fully electronic, with the medical industry's annual administrative transaction spend at $83 billion. The AMA's 2024 prior authorization survey puts physician burden at 13 hours per physician per week on PA work. These numbers translate directly into single-practice ROI math. At MSO scale, they translate into ROI math plus the portfolio-thesis line that makes operating partners actually care.
The rest of this article walks through how to build the full ROI model for a PE-backed MSO, the second-order effects that compound over time, the risks worth discounting in the vendor's pitch, and how to structure the pilot so the financial case is provable to the board within one quarter.
The ROI math template at MSO scale
The cleanest ROI model for a PE-backed MSO has four lines that compound, with the fourth one separating MSO math from single-practice math.
Line 1 — Per-PA labor cost reduction. Each acquired practice running 200 monthly PAs at $30/hr loaded staff cost and 30 min weighted average per PA = $36K annually per practice on direct PA labor. Automation cuts this 60–75% to ~$12K per practice. Across 10 acquired practices: $360K manual baseline drops to ~$120K = $240K annual labor recovery.
Line 2 — First-pass approval rate lift × per-PA revenue at risk. Manual workflows run 60–75% first-pass approval; automation typically lifts this to 85–92%. Each rework cycle adds 30–60 min of labor plus 1–3 days of delay. Across the MSO portfolio at 200 PAs × 10 practices × 25% rework reduction × $11 per rework + downstream revenue impact = $200K–$350K annual benefit.
Line 3 — Revenue recovery from PAs that would have dropped or expired. Under manual workflows, 3–8% of PA-dependent revenue gets lost to dropped or aged-out PAs. For an MSO with $50M in PA-dependent annual revenue across 10 acquired practices, that's $1.5M–$4M in revenue at risk. A platform that tightens the workflow recovers most of this — typically $400K–$800K annually.
Line 4 — Portfolio scalability (the PE-thesis line). This is the line that changes the MSO's economic model. Pre-automation, adding the 11th acquired practice requires hiring 2–3 new PA coordinators to handle the practice's volume. Post-automation, the existing central PA pod absorbs the additional volume with marginal overhead. The avoided headcount cost compounds across every future acquisition — at typical MSO acquisition cadences of 2–4 practices per year, this line alone often exceeds the direct labor recovery within 24 months.
Add the four lines together for a 10-practice MSO at year two: $240K labor + $275K approval lift + $600K revenue recovery + $200K avoided headcount on year-two acquisitions = $1.315M annual benefit against ~$150K platform cost. Payback during year one: month 3–5 on the cash math alone, with the portfolio thesis line compounding into year three and beyond.
Realistic payback periods at MSO scale
The payback window varies by MSO size, EHR portfolio complexity, and PA-volume distribution across acquired practices. Three representative scenarios.
5-practice MSO with cloud-native EHRs. Typical payback: 4–7 months. Cloud-native EHRs reach go-live in 4–6 weeks per practice, which means the full rollout takes 3–4 months. Labor recovery starts in month 2 at the first practice and ramps as additional practices come online. Year-one cumulative benefit usually clears $300K against $80K–$120K platform cost.
10-practice MSO with mixed EHRs (mostly cloud-native plus 2–3 Epic or on-prem). Typical payback: 6–9 months. Mixed-EHR rollouts take 5–7 months because Epic and on-prem deployments add 8–12 weeks each. Labor recovery on the cloud-native practices starts in month 2; full portfolio benefit usually arrives by month 9–10. Year-one cumulative benefit usually clears $500K–$700K against $100K–$180K platform cost.
20-practice MSO with significant Epic or on-prem footprint. Typical payback: 9–14 months. Large MSOs typically run multi-quarter rollouts with the highest-volume practices going first. Labor recovery starts in month 3 at the pilot practice and compounds slowly as additional practices come online. Year-one cumulative benefit usually clears $800K–$1.5M against $150K–$300K platform cost.
These scenarios assume the MSO captures the portfolio scalability line by acquiring additional practices during the rollout. MSOs in a non-acquisition holding pattern see slower payback because the portfolio thesis line doesn't compound until the next acquisition wave.
The second-order ROI on acquisition cadence
The most-discounted ROI line in vendor pitches is also the most important one to PE operating partners: the platform's effect on the MSO's acquisition cadence and post-acquisition integration cost.
Pre-automation, every acquired practice arrives with its own PA coordinator team that needs to be integrated, retrained on the MSO's payer mix, and absorbed into the broader operations. The integration cost is real — typically 3–6 months of operational drag per acquired practice before the new site's PA workflow stabilizes. PE operating partners track this as a hidden cost of acquisition that's often 5–15% of the practice's annual revenue depending on operational complexity.
Post-automation with a centralized PA platform, the acquisition integration looks different. The new practice's EHR integrates with the central platform (4–14 weeks depending on EHR pattern). The central PA pod absorbs the new practice's volume. Local PA coordinators redeploy to denial follow-up, patient outreach, or get released through attrition. The post-acquisition integration drag drops from 3–6 months to 1–3 months, which compounds across every future acquisition.
For a PE-backed MSO with a thesis of acquiring 2–4 practices annually for the next 3–5 years, the integration-cost reduction often exceeds the direct labor recovery by year three. This is the line that turns PA automation from a cost-saving project into a strategic capability the MSO is buying as part of the broader operating thesis.
Honey Health's Prior Authorization agent is built for this MSO operating model — multi-tenant by default, multi-EHR by architecture, and designed to absorb additional acquired practices into the central PA workflow with marginal per-practice overhead.
Risks and discounts worth applying to vendor-quoted ROI claims
Most vendor ROI claims need honest discounting before they survive board-level scrutiny. Four discount lines to apply during evaluation.
Peer-to-peer cases stay manual. Vendors typically quote labor recovery assuming 85%+ of PA volume runs straight-through. In reality, the 15–30% of cases that need peer-to-peer review or complex appeals require the same human time they always did. Apply a 10–15% haircut to vendor-quoted labor recovery to reflect this honest reality.
Payer policy churn drags rule-library performance. Payer policies change continuously. Even mature rule libraries occasionally lag the latest update, and the lag period costs the practice rework on cases that submitted against a stale policy. Apply a 5–10% haircut to vendor-quoted first-pass approval rate gains to reflect this ongoing maintenance reality.
Change-management drag at acquired practices. Some acquired practices resist centralization. Practice managers field patient questions they can't answer. Providers complain about losing visibility into PA status. The change-management overhead at resistant practices costs the central PA team 2–4 hours per week per practice during the first 90 days post-rollout. Apply a 10–15% haircut to vendor-quoted full-portfolio benefit during year one.
Implementation services and integration fees. Vendor pitch decks usually quote the platform subscription. They usually don't quote implementation services, EHR integration fees, ongoing payer-rule maintenance fees, or premium support. The fully-loaded annual platform cost is typically 25–50% higher than the headline subscription. Build the loaded cost into the ROI model up front.
Even with all four discounts applied, the math at PE-backed MSO scale usually still works cleanly. Better to defend a $700K year-two net benefit that the board believes than a $1.4M number that gets picked apart in due diligence.
How to structure the pilot so the board sees the financial case in one quarter
The business case that survives PE-level scrutiny requires showing the model's payback within the first 90 days. Three structural decisions make this work.
Pilot on the highest-volume acquired practice with the cleanest EHR fit. Most acquired practices have a single anchor location with the highest PA volume and a cloud-native EHR. Pilot there first to maximize labor recovery and minimize integration timeline. The pilot should produce 50–100 PAs per week — enough to demonstrate real production benefit without exposing the MSO to material risk if anything breaks.
Document the pre-implementation baseline rigorously. Pull 30 days of data on PA volume by payer and procedure, median TAT, denial rate by reason code, and staff hours per PA. Without the baseline, the ROI claim post-go-live is unprovable. The operating partner reviewing the case wants to see specific numbers that the platform improved against, not generic claims.
Require monthly KPI reporting in the vendor contract. TAT reduction, first-pass approval rate lift, staff hours per PA, and full-portfolio benefit projection from the pilot data. Strong vendors will commit to these in writing with remediation clauses. Vendors that won't are vendors whose ROI claims should be discounted heavily during board review.
By the end of the first quarter post-go-live at the pilot practice, the MSO should have:
- A documented labor recovery rate from the pilot
- A documented TAT and first-pass approval rate lift
- A scaled-up year-two projection for the full portfolio based on the pilot data
- A vendor commitment in writing on the full-portfolio rollout timeline
This is the package that lets the PE operating partner approve the full rollout and defend the spend to the board.
Frequently asked questions
How quickly does the ROI math start showing up at a PE-backed MSO?
The first measurable benefit shows up in month 2 at the pilot practice. Full portfolio benefit takes 6–10 months for a 5–10 practice MSO and 9–14 months for a 20+ practice MSO. The portfolio scalability line compounds into year two and beyond as the MSO continues acquiring practices that absorb into the central platform with marginal overhead.
Will adopting a centralized PA platform require us to reduce headcount at acquired practices?
Most MSOs redeploy local PA coordinators rather than reduce headcount, especially in the first 12 months. Recovered hours go to denial follow-up, patient outreach, appeal work, and peer-to-peer coordination at each practice. Some MSOs reduce headcount through attrition as they layer in additional acquired practices, with the existing central PA pod absorbing the additional volume. The financial case typically works better when hours redeploy into revenue-positive local work that compounds the centralization ROI.
How should the operating partner evaluate vendor ROI claims?
Apply four discounts: 10–15% for peer-to-peer and complex appeals that stay manual, 5–10% for payer policy churn that drags rule-library performance, 10–15% for change-management overhead at acquired practices, and 25–50% loaded platform cost above the headline subscription. Even with all four applied, the math usually still works at MSO scale. Vendors whose claims don't survive the discounts are vendors whose ROI is unfounded.
How do we handle the timeline mismatch between the rollout and the PE hold period?
Most PE-backed MSO holds run 3–5 years. A 6–14 month rollout leaves 2–4 years of full-portfolio benefit running through the hold period, plus the portfolio scalability line compounding through acquisitions during the hold. The math typically works even at the back end of a hold because the next owner inherits a higher-performing operational platform. Operating partners should think about PA automation as adding to the MSO's exit multiple, not just to current-year EBITDA.
What should the board see at 30, 60, and 90 days post-go-live?
At 30 days: pilot practice labor recovery rate, initial TAT improvement, first-pass approval rate change versus baseline. At 60 days: stabilized pilot metrics, second-practice rollout timeline confirmation, vendor commitment on full-portfolio integration plan. At 90 days: scaled year-two projection based on pilot data, full-rollout timeline with milestones, total fully-loaded platform cost and net benefit by quarter through year two. This package is what lets the board approve the full rollout with confidence.
